标题
Progress and Challenges in RSV Prophylaxis and Vaccine Development
作者
关键词
-
出版物
JOURNAL OF INFECTIOUS DISEASES
Volume 208, Issue suppl 3, Pages S177-S183
出版商
Oxford University Press (OUP)
发表日期
2013-11-21
DOI
10.1093/infdis/jit512
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Nanoparticle Vaccines Encompassing the Respiratory Syncytial Virus (RSV) G Protein CX3C Chemokine Motif Induce Robust Immunity Protecting from Challenge and Disease
- (2013) Patricia A. Jorquera et al. PLoS One
- Increased Genetic and Phenotypic Stability of a Promising Live-Attenuated Respiratory Syncytial Virus Vaccine Candidate by Reverse Genetics
- (2012) C. Luongo et al. JOURNAL OF VIROLOGY
- Respiratory Syncytial Virus Modified by Deletions of the NS2 Gene and Amino Acid S1313 of the L Polymerase Protein Is a Temperature-Sensitive, Live-Attenuated Vaccine Candidate That Is Phenotypically Stable at Physiological Temperature
- (2012) C. Luongo et al. JOURNAL OF VIROLOGY
- Nucleoprotein Nanostructures Combined with Adjuvants Adapted to the Neonatal Immune Context: A Candidate Mucosal RSV Vaccine
- (2012) Aude Remot et al. PLoS One
- Respiratory Syncytial Virus Fusion Glycoprotein Expressed in Insect Cells Form Protein Nanoparticles That Induce Protective Immunity in Cotton Rats
- (2012) Gale Smith et al. PLoS One
- Combination Therapy Using Monoclonal Antibodies against Respiratory Syncytial Virus (RSV) G Glycoprotein Protects from RSV Disease in BALB/c Mice
- (2012) Hayat Caidi et al. PLoS One
- Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention
- (2012) M. Magro et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Enhanced immune responses and protection by vaccination with respiratory syncytial virus fusion protein formulated with CpG oligodeoxynucleotide and innate defense regulator peptide in polyphosphazene microparticles
- (2012) S. Garlapati et al. VACCINE
- Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration
- (2012) Aalzen de Haan et al. VACCINE
- Nonclinical phenotypic and genotypic analyses of a Phase 1 pediatric respiratory syncytial virus vaccine candidate MEDI-559 (rA2cp248/404/1030ΔSH) at permissive and non-permissive temperatures
- (2012) Jeanne H. Schickli et al. VIRUS RESEARCH
- Respiratory syncytial virus vaccine development
- (2011) Julia L Hurwitz Expert Review of Vaccines
- Nanobodies® Specific for Respiratory Syncytial Virus Fusion Protein Protect Against Infection by Inhibition of Fusion
- (2011) Bert Schepens et al. JOURNAL OF INFECTIOUS DISEASES
- Identification of nucleolin as a cellular receptor for human respiratory syncytial virus
- (2011) Farnoosh Tayyari et al. NATURE MEDICINE
- Respiratory Syncytial Virus-associated Hospitalizations Among Infants and Young Children in the United States, 1997–2006
- (2011) Lauren J. Stockman et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- A Novel Inactivated Intranasal Respiratory Syncytial Virus Vaccine Promotes Viral Clearance without Th2 Associated Vaccine-Enhanced Disease
- (2011) Dennis M. Lindell et al. PLoS One
- Safety and immunogenicity of a novel nanoemulsion mucosal adjuvant W805EC combined with approved seasonal influenza antigens
- (2011) L.R. Stanberry et al. VACCINE
- Sendai virus-based RSV vaccine protects African green monkeys from RSV infection
- (2011) Bart G. Jones et al. VACCINE
- Use of defined TLR ligands as adjuvants within human vaccines
- (2010) Malcolm S. Duthie et al. IMMUNOLOGICAL REVIEWS
- Therapeutic targeting of respiratory syncytial virus G-protein
- (2010) Lawrence M Kauvar et al. Immunotherapy
- Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis
- (2010) Harish Nair et al. LANCET
- Lipopeptide-adjuvanted respiratory syncytial virus virosomes: A safe and immunogenic non-replicating vaccine formulation
- (2010) Toon Stegmann et al. VACCINE
- Therapeutic Monoclonal Antibody Treatment Targeting Respiratory Syncytial Virus (RSV) G Protein Mediates Viral Clearance and Reduces the Pathogenesis of RSV Infection in BALB/c Mice
- (2009) Lia M. Haynes et al. JOURNAL OF INFECTIOUS DISEASES
- Protective Efficacy and Immunogenicity of an Adenoviral Vector Vaccine Encoding the Codon-Optimized F Protein of Respiratory Syncytial Virus
- (2009) R. Kohlmann et al. JOURNAL OF VIROLOGY
- Vaccination To Induce Antibodies Blocking the CX3C-CX3CR1 Interaction of Respiratory Syncytial Virus G Protein Reduces Pulmonary Inflammation and Virus Replication in Mice
- (2009) W. Zhang et al. JOURNAL OF VIROLOGY
- Induction of immune response to the 17 kDa OMPA Burkholderia cenocepacia polypeptide and protection against pulmonary infection in mice after nasal vaccination with an OMP nanoemulsion-based vaccine
- (2009) P. E. Makidon et al. MEDICAL MICROBIOLOGY AND IMMUNOLOGY
- The Burden of Respiratory Syncytial Virus Infection in Young Children
- (2009) Caroline Breese Hall et al. NEW ENGLAND JOURNAL OF MEDICINE
- Motavizumab for Prophylaxis of Respiratory Syncytial Virus in High-Risk Children: A Noninferiority Trial
- (2009) X. Carbonell-Estrany et al. PEDIATRICS
- Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease
- (2008) Maria Florencia Delgado et al. NATURE MEDICINE
- Pre-Clinical Evaluation of a Novel Nanoemulsion-Based Hepatitis B Mucosal Vaccine
- (2008) Paul E. Makidon et al. PLoS One
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started